Vor Biopharma Inc. logo

Vor Biopharma Inc.

NASDAQ:VOR

Overview | Financials
Company Name Vor Biopharma Inc.
Symbol VOR
Currency USD
Price 0.934
Market Cap 63,898,159
Dividend Yield 0%
52-week-range 0.7 - 3.14
Industry Biotechnology
Sector Healthcare
CEO Dr. Robert Ang M.B.A., M.D., MBBS
Website https://www.vorbio.com

An error occurred while fetching data.

About Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed

Related Stocks

Quipt Home Medical Corp. logo

Quipt Home Medical Corp.

QIPT

2.88 USD

NeuroPace, Inc. logo

NeuroPace, Inc.

NPCE

6.82 USD

Meihua International Medical Technologies Co., Ltd. logo

Meihua International Medical Technologies Co., Ltd.

MHUA

1.03 USD

Compugen Ltd. logo

Compugen Ltd.

CGEN

1.9 USD

Allakos Inc. logo

Allakos Inc.

ALLK

0.54 USD

Savara Inc. logo

Savara Inc.

SVRA

4.44 USD

Sensus Healthcare, Inc. logo

Sensus Healthcare, Inc.

SRTS

6.07 USD

Clene Inc. logo

Clene Inc.

CLNN

5.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD